Skip to content

Effectiveness of Continuous Negative External Pressure in Preventing Upper Airway Impairment During Routine Colonoscopy

Effectiveness and Safety of Continuous Negative External Pressure (cNEP) in Preventing Sedation-Related Respiratory Impairment in Adults Undergoing Colonoscopy

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01895062
Enrollment
54
Registered
2013-07-10
Start date
2013-03-31
Completion date
2014-03-31
Last updated
2014-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Obstruction, Apnea, Hypopnea

Keywords

colonoscopy, oxygen desaturation

Brief summary

The primary goal of this study is to determine the effectiveness and safety of delivering continuous negative external pressure (cNEP) to the upper airway as a means of preventing episodes of respiratory impairment (RI) such as hypoxemia, apnea and hypoventilation associated with the use of intravenous sedation in elective colonoscopy in adult patients.

Interventions

DEVICEAirway Management System (AMS)

The AMS consists of a silicone collar applied under the mandible to the anterior surface of the neck. The collar is attached to a vacuum source which delivers continuous negative external pressure to the upper airway.

Sponsors

5i Sciences, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Male or female subjects undergoing elective colonoscopy at the Study Site who have fewer than three or more than three positive responses on the STOP BANG questionnaire

Exclusion criteria

* Presence of severe cardiopulmonary or neurologic disease as determined by the investigator * History of vascular fragility associated with cutaneous pressure * History of hypersensitivity to silicone * Inability to properly fit cNEP collar to the subject * The presence of excessive facial hair in the region where the cNEP collar is positioned * Known carotid vascular disease, previous major neck surgery or radiation therapy to the cervical region * Presence of anatomical abnormalities in the neck or pharyngeal region (such as enlarged tonsils) * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
RI Events in the cNEP Group Compared to the no cNEP Group, Where RI is Defined as Either: i Oxygen Saturation < 90% or ii. Apneas/Hypopneas of > 15 Sec Duration i. Oxygen Saturation <90% ii. Presence of Apneas or Hypopneas1 hourMean RI events in the no cNEP group was 3.5 compared to 1.92 in the cNEP group (p=0.022)

Secondary

MeasureTime frameDescription
The Safety of cNEP as Determined by Adverse Events Reported by the Investigators.1 hour
The Incidence of Subjects With One or More RI in the cNEP Group Compared to the no cNEP Group.1 hour
The Frequency of Interventions to Alleviate RI in the cNEP Group Compared to the no cNEP Group.1 hourinterventions such as reduction of sedative medication or jaw thrust.

Countries

United States

Participant flow

Participants by arm

ArmCount
Active cNEP @ -45cmw
cNEP @ -45 cmw is applied to the anterior surface of the neck with a soft collar attached to a vacuum source. Airway Management System (AMS): The AMS consists of a silicone collar applied under the mandible to the anterior surface of the neck. The collar is attached to a vacuum source which delivers continuous negative external pressure to the upper airway.
30
no Intervention
Routine care is administered without the application of cNEP.
24
Total54

Baseline characteristics

CharacteristicActive cNEP @ -45cmwno InterventionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
8 Participants6 Participants14 Participants
Age, Categorical
Between 18 and 65 years
22 Participants18 Participants40 Participants
Age, Continuous60 years60 years60 years
History of sleep apnea2 participants2 participants4 participants
Region of Enrollment
United States
30 participants24 participants54 participants
Sex: Female, Male
Female
18 Participants9 Participants27 Participants
Sex: Female, Male
Male
12 Participants15 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 300 / 24
serious
Total, serious adverse events
0 / 300 / 24

Outcome results

Primary

RI Events in the cNEP Group Compared to the no cNEP Group, Where RI is Defined as Either: i Oxygen Saturation < 90% or ii. Apneas/Hypopneas of > 15 Sec Duration i. Oxygen Saturation <90% ii. Presence of Apneas or Hypopneas

Mean RI events in the no cNEP group was 3.5 compared to 1.92 in the cNEP group (p=0.022)

Time frame: 1 hour

Population: Not all subjects were evaluable due to malfunction of the respiratory monitoring equipment in several.

ArmMeasureValue (MEAN)
Active cNEP @ -45cmwRI Events in the cNEP Group Compared to the no cNEP Group, Where RI is Defined as Either: i Oxygen Saturation < 90% or ii. Apneas/Hypopneas of > 15 Sec Duration i. Oxygen Saturation <90% ii. Presence of Apneas or Hypopneas1.92 RI events
no InterventionRI Events in the cNEP Group Compared to the no cNEP Group, Where RI is Defined as Either: i Oxygen Saturation < 90% or ii. Apneas/Hypopneas of > 15 Sec Duration i. Oxygen Saturation <90% ii. Presence of Apneas or Hypopneas3.5 RI events
p-value: <0.022t-test, 2 sided
Secondary

The Frequency of Interventions to Alleviate RI in the cNEP Group Compared to the no cNEP Group.

interventions such as reduction of sedative medication or jaw thrust.

Time frame: 1 hour

ArmMeasureValue (NUMBER)
Active cNEP @ -45cmwThe Frequency of Interventions to Alleviate RI in the cNEP Group Compared to the no cNEP Group.1 interventions to restore airway
no InterventionThe Frequency of Interventions to Alleviate RI in the cNEP Group Compared to the no cNEP Group.0 interventions to restore airway
Secondary

The Incidence of Subjects With One or More RI in the cNEP Group Compared to the no cNEP Group.

Time frame: 1 hour

Secondary

The Safety of cNEP as Determined by Adverse Events Reported by the Investigators.

Time frame: 1 hour

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026